Author:
Tamaiev Jonathan,Bergson Zachary,Sun Xiaowei,Roy Dipta,Desai Gunjan,Lencz Todd,Malhotra Anil,Zhang Jian-Ping
Publisher
Springer Science and Business Media LLC
Subject
Behavioral Neuroscience,Public Health, Environmental and Occupational Health
Reference36 articles.
1. Connolly KR, Thase ME. The clinical management of bipolar disorder: a review of evidence-based guidelines. Prim Care Companion CNS Disord. 2011;13:PCC.10r01097.
2. Kane JM, Leucht S, Carpenter D, Docherty JP, Expert Consensus Panel for Optimizing Pharmacologic Treatment of Psychotic Disorders. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. J Clin Psychiatry. 2003;64 Suppl 12:5–19.
3. Robinson DG, et al. Prescription practices in the treatment of first-episode schizophrenia spectrum disorders: data from the national RAISE-ETP study. Am J Psychiatry. 2015;172:237–48.
4. Correll CU, Kishimoto T, Kane JM. Randomized controlled trials in schizophrenia: opportunities, limitations, and trial design alternatives. Dialogues Clin Neurosci. 2011;13:155–72.
5. Lieberman JA, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353:1209–23.